Inventor
FELDHAUS ANDREW L
US15 patents
⚠️ This page may combine multiple inventors who share the name “FELDHAUS ANDREW L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZYMOGENETICS INC
5 patentsUS6902729B2Jun 7, 2005
Murine interferon-α
ZYMOGENETICS INC27 citations92
US6312924B1Nov 6, 2001
Murine interferon-α
ZYMOGENETICS INC19 citations92
US6548056B2Apr 15, 2003
Murine interferon-α
ZYMOGENETICS INC9 citations74
US6235708B1May 22, 2001
Testis-specific cystatin-like protein cystatin T
ZYMOGENETICS INC13 citations73
US6245529B1Jun 12, 2001
Testis-specific cystatin-like protein cystatin T
ZYMOGENETICS INC4 citations62
TARGETED GENETICS CORP
4 patentsUS6936466B2Aug 30, 2005
Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors
TARGETED GENETICS CORP47 citations95
US6346415B1Feb 12, 2002
Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors
TARGETED GENETICS CORP40 citations92
US5874556AFeb 23, 1999
Hybrid genes for use in the production of TH -independent cytotoxic T cells
TARGETED GENETICS CORP25 citations92
US6593124B1Jul 15, 2003
Hybrid genes for expression of stimulatory factors in activated T cells
TARGETED GENETICS CORP0 citations52
ALDERBIO HOLDINGS LLC
4 patentsUS9957321B2May 1, 2018
Anti-IL-6 antibodies for the treatment of oral mucositis
ALDERBIO HOLDINGS LLC15 citations92
US9481725B2Nov 1, 2016
Antibodies to HGF and compositions containing
ALDERBIO HOLDINGS LLC16 citations92
US10100108B2Oct 16, 2018
Antibodies to HGF and compositions containing
ALDERBIO HOLDINGS LLC6 citations84
US9732150B2Aug 15, 2017
Therapeutic use of antibodies to HGF
ALDERBIO HOLDINGS LLC6 citations73